05/23/2025
4:30 PM | Akero Therapeutics (Issuer)
Lamy Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2025
3:20 PM | Akero Therapeutics (Subject)
Lamy Patrick (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/19/2025
6:06 PM | Akero Therapeutics (Issuer)
Yale Catriona (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2025
7:13 AM | Akero Therapeutics (Subject)
GENERAL ATLANTIC, L.P. (Filed by)
| Form SCHEDULE 13G/A | |
05/14/2025
11:24 AM | Akero Therapeutics (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
| Form SCHEDULE 13G/A | |
05/13/2025
8:11 PM | Akero Therapeutics (Issuer)
Cheng Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/12/2025
5:47 PM | Akero Therapeutics (Subject)
Cheng Andrew (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/12/2025
9:44 AM | Akero Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SCHEDULE 13G/A | |
05/12/2025
6:14 AM | Akero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/12/2025
6:30 AM | Akero Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/09/2025
6:18 PM | Akero Therapeutics (Issuer)
Lamy Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for AKRO and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Akero Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
05/08/2025
6:34 PM | Akero Therapeutics (Issuer)
Rolph Timothy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/06/2025
3:41 PM | Akero Therapeutics (Subject)
Rolph Timothy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/28/2025
5:22 PM | Akero Therapeutics (Issuer)
Rolph Timothy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/28/2025
7:00 AM | Akero Therapeutics (Filer)
| Form DEF 14A | |
04/28/2025
7:23 AM | Akero Therapeutics (Filer)
| Form ARS | |
04/16/2025
5:00 PM | Akero Therapeutics (Issuer)
Yale Catriona (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/11/2025
5:00 PM | Akero Therapeutics (Issuer)
Cheng Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2025
5:00 PM | Akero Therapeutics (Issuer)
Rolph Timothy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/07/2025
3:24 PM | Akero Therapeutics (Subject)
Lamy Patrick (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/27/2025
6:42 PM | Akero Therapeutics (Issuer)
Graham G. Walmsley (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2025
4:30 PM | Akero Therapeutics (Issuer)
Yale Catriona (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2025
8:18 PM | Akero Therapeutics (Issuer)
Cheng Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2025
7:24 PM | Akero Therapeutics (Issuer)
White William Richard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2025
7:30 PM | Akero Therapeutics (Issuer)
Yale Catriona (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2025
7:33 PM | Akero Therapeutics (Issuer)
Young Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2025
7:18 PM | Akero Therapeutics (Issuer)
Rolph Timothy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2025
5:00 PM | Akero Therapeutics (Issuer)
Cheng Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
4:30 PM | Akero Therapeutics (Issuer)
Rolph Timothy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2025
5:55 PM | Akero Therapeutics (Issuer)
Lamy Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2025
5:56 PM | Akero Therapeutics (Issuer)
Young Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2025
3:05 PM | Akero Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/28/2025
7:30 AM | Akero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/28/2025
6:30 AM | Akero Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/21/2025
4:31 PM | Akero Therapeutics (Issuer)
Yale Catriona (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2025
11:58 AM | Akero Therapeutics (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
| Form SCHEDULE 13G/A | |
02/14/2025
8:00 AM | Akero Therapeutics (Subject)
RTW INVESTMENTS, LP (Filed by)
| Form SCHEDULE 13G/A | |
02/11/2025
8:30 PM | Akero Therapeutics (Issuer)
Cheng Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/07/2025
6:54 PM | Akero Therapeutics (Issuer)
Graham G. Walmsley (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/07/2025
5:05 PM | Akero Therapeutics (Issuer)
Rolph Timothy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2025
8:03 AM | Akero Therapeutics (Issuer)
Young Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
URGENT: Someone's Moving Gold Out of London... (Ad) People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “gold analysts” have it all wrong…
They tell you to invest in gold ETFs - because the popular mining ETFs will someday catch fire and close the price gap with spot gold.  Go here to learn about my Top Four picks for the coming bull mania. |
01/31/2025
8:14 AM | Akero Therapeutics (Issuer)
Yale Catriona (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2025
8:14 AM | Akero Therapeutics (Issuer)
Yale Catriona (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2025
6:52 AM | Akero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/29/2025
7:43 PM | Akero Therapeutics (Issuer)
Cheng Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2025
7:43 PM | Akero Therapeutics (Issuer)
Lamy Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2025
7:43 PM | Akero Therapeutics (Issuer)
Rolph Timothy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2025
4:08 PM | Akero Therapeutics (Filer)
| Form 424B5 | |
01/27/2025
8:35 PM | Akero Therapeutics (Subject)
| Form FWP | |
01/27/2025
5:07 PM | Akero Therapeutics (Issuer)
Cheng Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/27/2025
5:08 PM | Akero Therapeutics (Issuer)
Young Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/27/2025
3:53 PM | Akero Therapeutics (Filer)
| Form 424B5 | |
01/27/2025
3:23 PM | Akero Therapeutics (Subject)
Lamy Patrick (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/27/2025
3:24 PM | Akero Therapeutics (Subject)
Yale Catriona (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/27/2025
3:24 PM | Akero Therapeutics (Subject)
Yale Catriona (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/27/2025
3:06 PM | Akero Therapeutics (Subject)
Rolph Timothy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/27/2025
7:31 AM | Akero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/10/2025
6:38 PM | Akero Therapeutics (Issuer)
Rolph Timothy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
1:08 PM | Akero Therapeutics (Issuer)
Young Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/30/2024
7:20 PM | Akero Therapeutics (Issuer)
Rolph Timothy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2024
7:59 PM | Akero Therapeutics (Issuer)
White William Richard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2024
8:01 PM | Akero Therapeutics (Issuer)
Yale Catriona (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2024
8:03 PM | Akero Therapeutics (Issuer)
Lamy Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2024
8:08 PM | Akero Therapeutics (Issuer)
Young Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2024
7:50 PM | Akero Therapeutics (Issuer)
Cheng Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2024
7:52 PM | Akero Therapeutics (Issuer)
Rolph Timothy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2024
7:56 PM | Akero Therapeutics (Issuer)
Gangloff Scott A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2024
7:38 PM | Akero Therapeutics (Issuer)
Young Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2024
7:44 PM | Akero Therapeutics (Issuer)
Rolph Timothy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2024
7:24 PM | Akero Therapeutics (Issuer)
Cheng Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2024
7:26 PM | Akero Therapeutics (Issuer)
White William Richard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2024
7:28 PM | Akero Therapeutics (Issuer)
Yale Catriona (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2024
7:29 PM | Akero Therapeutics (Issuer)
Lamy Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2024
3:25 PM | Akero Therapeutics (Subject)
Rolph Timothy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/19/2024
8:57 PM | Akero Therapeutics (Issuer)
Yale Catriona (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2024
5:51 AM | Akero Therapeutics (Subject)
RTW INVESTMENTS, LP (Filed by)
| Form SC 13G/A | |
11/13/2024
8:45 AM | Akero Therapeutics (Subject)
ALKEON CAPITAL MANAGEMENT LLC (Filed by)
| Form SC 13G/A | |
11/08/2024
4:06 PM | Akero Therapeutics (Issuer)
Yale Catriona (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2024
9:52 AM | Akero Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
11/08/2024
6:30 AM | Akero Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/08/2024
6:19 AM | Akero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2024
4:01 PM | Akero Therapeutics (Subject)
Yale Catriona (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/05/2024
8:00 AM | Akero Therapeutics (Issuer)
Cheng Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2024
8:04 AM | Akero Therapeutics (Issuer)
Young Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2024
7:59 PM | Akero Therapeutics (Issuer)
Yale Catriona (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2024
3:46 PM | Akero Therapeutics (Subject)
Yale Catriona (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/18/2024
7:57 PM | Akero Therapeutics (Issuer)
Cheng Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/17/2024
10:13 AM | Akero Therapeutics (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
10/16/2024
7:06 PM | Akero Therapeutics (Issuer)
Yale Catriona (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/16/2024
7:06 PM | Akero Therapeutics (Issuer)
Young Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/16/2024
3:50 PM | Akero Therapeutics (Subject)
Cheng Andrew (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Watch This Robotics Demo Before July 23rd (Ad) Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%...
Just did a demo of what Nvidia’s CEO said will be "the first multitrillion-dollar robotics industry." Click here to watch the demo… |
10/15/2024
3:38 PM | Akero Therapeutics (Subject)
Yale Catriona (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/15/2024
7:04 AM | Akero Therapeutics (Subject)
Yale Catriona (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/03/2024
7:09 PM | Akero Therapeutics (Issuer)
Young Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/01/2024
3:03 PM | Akero Therapeutics (Subject)
Young Jonathan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/23/2024
5:00 PM | Akero Therapeutics (Issuer)
Yale Catriona (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2024
8:19 PM | Akero Therapeutics (Issuer)
Yale Catriona (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2024
3:34 PM | Akero Therapeutics (Subject)
Yale Catriona (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/13/2024
4:14 PM | Akero Therapeutics (Issuer)
Yale Catriona (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2024
4:16 PM | Akero Therapeutics (Issuer)
Young Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
